lly and nsph are now partnering up to create new products in the medical field. as lly restructures it would make perfect sense to gobble up little nsph with all their patents on gold and silver nanotechnology. even if no acquisition takes place nsph is surely to benefit from their current joint venture.
Imagine seeing a small, private list of stocks with earnings that are growing like wildfire. And yet, their shares have somehow remained underpriced and undervalued. That's the strategy behind Growth Trader. Developed by Zacks' world-class stock screening expert, our tests against historical data show an average gain of +57.2% per year!Learn More>>
Find Winning Stocks Quickly with Research Wizard, a powerful desktop software program. Start with easy-to-use pre-loaded strategies, then develop your own. Backtest against years of historical data to see how your approach works in any market. Start a Free Trial Today >>
Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>
With Zacks Method for Trading you'll transform yourself into a Master Stock Trader, one simple step at a time. Get step-by-step instructions and learn how to use the 26% per year Zacks Rank system to find market-beating stocks on your own, fully exploiting the system that beat the market 18 of the last 20 years. Find out how >>
Comments: 1 | Comment
Comments: 0 | Comment
Comments: 0 | Comment